Atherosclerosis severity but not undiagnosed diabetes predicts new cardiovascular events of subjects in secondary cardiovascular prevention

被引:9
作者
Rizza, Stefano [1 ]
Copetti, Massimiliano [2 ]
Cardellini, Marina [1 ]
Porzio, Ottavia [1 ]
Luzi, Alessio [1 ]
Pecchioli, Chiara [1 ]
Martelli, Eugenio [4 ]
Valentini, Alessia [1 ]
Ippoliti, Arnaldo [4 ]
Romeo, Francesco [1 ]
Pellegrini, Fabio [2 ,3 ]
Lauro, Davide [1 ]
Lauro, Renato [1 ]
Federici, Massimo [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy
[2] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy
[3] Consorzio Mario Negri Sud, Unit Biostat, Lab Clin Epidemiol Diabet & Chron Dis, Chieti, Italy
[4] Univ Roma Tor Vergata, Dept Surg, I-00133 Rome, Italy
关键词
Cardiovascular risk; Diabetes; Atherosclerosis; Inflammation; CORONARY-HEART-DISEASE; RISK; MORTALITY; MELLITUS; OUTCOMES;
D O I
10.1016/j.atherosclerosis.2012.04.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Undiagnosed diabetes (DM2), especially in individuals that have experienced a major atherosclerotic vascular event, could increase the risk of a second major cardiovascular (CV) event. The aim of this study was to evaluate the impact of type 2 diabetes (DM2), diagnosed after a major cardiovascular event, on subsequent CV disease in high risk individuals. Methods: 411 subjects without known DM2 and with a history of a prior major CV event were followed for a second major CV event (fatal and nonfatal MI, fatal and nonfatal stroke or any arterial revascularization procedure). At baseline, each individual underwent a physical, biochemical examination, an OGTT and dosed A1c. In addition, patients were classified as having monovascular or polyvascular disease. The average follow-up duration was 31 months. Results: The incidence of second CV events was 10.70 per 100 person-years (114 events/1066 person-years). The diagnosis of occult DM2 was not associated with major CV events, either using A1c values >= 6.5%, fasting glucose >= 126 mg/dL or 2 h post-load glucose >= 200 mg/dL. Polyvascular disease was the only significant predictor of a second major CV event (HR 2.60, 95% CI 1.72-3.95) after adjustment for age, BMI, smoking status, systolic blood pressure, high-density and low-density lipoprotein cholesterol and high sensitivity C-reactive protein. Conclusion: DM2 that was newly diagnosed after established vascular atherosclerotic disease did not increase the risk of new major CV events. In our population only the polyvascular disease was able to identify the subjects at high risk for a second major cardiovascular event. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:448 / 453
页数:6
相关论文
共 20 条
  • [1] [Anonymous], NIH PUBLICATION
  • [2] [Anonymous], 2001, 3 NIH NCEP EXP PAN D
  • [3] Newly detected abnormal glucose tolerance:: an important predictor of long-term outcome after myocardial infarction
    Bartnik, M
    Malmberg, K
    Norhammar, A
    Tenerz, Å
    Öhrvik, J
    Rydén, L
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (22) : 1990 - 1997
  • [4] Screening for coronary heart disease: Recommendation statement
    Berg, AO
    Allan, JD
    Calonge, N
    Frame, P
    Garcia, J
    Harris, RP
    Johnson, MS
    Klein, JD
    Loveland-Cherry, C
    Moyer, VA
    Orleans, CT
    Siu, AL
    Teutsch, SM
    Westhoff, C
    Woolf, SH
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (07) : 569 - 572
  • [5] Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
    Bhatt, Deepak L.
    Eagle, Kim A.
    Ohman, E. Magnus
    Hirsch, Alan T.
    Goto, Shinya
    Mahoney, Elizabeth M.
    Wilson, Peter W. F.
    Alberts, Mark J.
    D'Agostino, Ralph
    Liau, Chiau-Suong
    Mas, Jean-Louis
    Roether, Joachim
    Smith, Sidney C., Jr.
    Salette, Genevieve
    Contant, Charles F.
    Massaro, Joseph M.
    Steg, Ph. Gabriel
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (12): : 1350 - 1357
  • [6] Effects of Optimal Medical Treatment With or Without Coronary Revascularization on Angina and Subsequent Revascularizations in Patients With Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease
    Dagenais, Gilles R.
    Lu, Jiang
    Faxon, David P.
    Kent, Kenneth
    Lago, Rodrigo M.
    Lezama, Carlos
    Hueb, Whady
    Weiss, Melvin
    Slater, James
    Frye, Robert L.
    [J]. CIRCULATION, 2011, 123 (14) : 1492 - +
  • [7] ACCF/AHA 2007 Clinical Expert Consensus Document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain - A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography
    Greenland, Philip
    Bonow, Robert O.
    Brundage, Bruce H.
    Budoff, Matthew J.
    Eisenberg, Mark J.
    Grundy, Scott M.
    Lauer, Michael S.
    Post, Wendy S.
    Raggi, Paolo
    Redberg, Rita F.
    Rodgers, George P.
    Shaw, Leslee J.
    Taylor, Allen J.
    Weintraub, William S.
    [J]. CIRCULATION, 2007, 115 (03) : 402 - 426
  • [8] Diabetes and decline in heart disease mortality in US adults
    Gu, K
    Cowie, CC
    Harris, MI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (14): : 1291 - 1297
  • [9] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    Haffner, SM
    Lehto, S
    Rönnemaa, T
    Pyörälä, K
    Laakso, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) : 229 - 234
  • [10] Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies
    He, Li-ping
    Tang, Xin-yi
    Ling, Wen-hua
    Chen, Wei-qing
    Chen, Yu-ming
    [J]. HEART, 2010, 96 (05) : 339 - 346